CAPELLI, Irene
 Distribuzione geografica
Continente #
NA - Nord America 446
EU - Europa 222
AS - Asia 197
SA - Sud America 9
Totale 874
Nazione #
US - Stati Uniti d'America 436
IT - Italia 200
BD - Bangladesh 142
SG - Singapore 29
CN - Cina 9
DE - Germania 7
BR - Brasile 6
GB - Regno Unito 4
JM - Giamaica 4
JP - Giappone 4
CA - Canada 3
FI - Finlandia 3
HK - Hong Kong 3
IN - India 3
VN - Vietnam 3
CO - Colombia 2
ID - Indonesia 2
MX - Messico 2
PT - Portogallo 2
AR - Argentina 1
FR - Francia 1
GT - Guatemala 1
HR - Croazia 1
LB - Libano 1
LU - Lussemburgo 1
NL - Olanda 1
PK - Pakistan 1
RU - Federazione Russa 1
SE - Svezia 1
Totale 874
Città #
Ashburn 133
San Jose 104
Milan 60
New York 58
Miano 18
Singapore 15
Buffalo 13
Rome 9
Bologna 8
Los Angeles 8
Naples 7
Santa Clara 6
Chicago 5
Dallas 5
Fairfield 5
Pasadena 4
Atlanta 3
Bari 3
Beijing 3
Florence 3
Hong Kong 3
Kingston 3
London 3
Munich 3
Tokyo 3
Turin 3
Concesio 2
Denver 2
Des Moines 2
Kansas City 2
Milwaukee 2
Montreal 2
Philadelphia 2
Pittsburgh 2
Queens 2
Albany 1
Anaheim 1
Ann Arbor 1
Arcevia 1
Atlantic Highlands 1
Austin 1
Baraboo 1
Bergamo 1
Boca Raton 1
Boerne 1
Bogotá 1
Brescia 1
Brooklyn 1
Cartago 1
Catania 1
Charlotte 1
Chennai 1
Chester 1
Cincinnati 1
Columbia 1
Columbia City 1
Davis 1
Durazzano 1
Düsseldorf 1
East Jakarta 1
Elgin 1
Evanston 1
Falls Church 1
Fresno 1
Genoa 1
Giffone 1
Grand Rapids 1
Greeley 1
Greenwood 1
Guatemala City 1
Hamburg 1
Hanoi 1
Helsinki 1
Hempstead 1
Ho Chi Minh City 1
Igarapé-Miri 1
Jackson 1
Jakarta 1
Jefferson 1
Juneau 1
Katy 1
Lappeenranta 1
Lauterbourg 1
Lendinara 1
Louin 1
Louisville 1
L’Aquila 1
Macere 1
Mandatoriccio 1
Manning 1
Maricá 1
Mascalucia 1
Mexico City 1
Miami 1
Miami Beach 1
Modena 1
Molinara 1
Monroe 1
Moscow 1
Nanning 1
Totale 571
Nome #
A Pathogenic Galactosidase A Mutation Coexisting With an MYBPC3 Mutation in a Female Patient With Hypertrophic Cardiomyopathy 143
Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial 17
Nutritional Vitamin D in CKD: Should We Measure? Should We Treat? 16
Fabry disease: a rare disorder calling for personalized medicine 16
Investigational agents for autosomal dominant polycystic kidney disease: preclinical and early phase study insights 14
No evidence of Fabry disease in a patient with the new p.Met70Val GLA gene variant 13
DNAJB11 Mutation in ADPKD Patients: Clinical Characteristics in a Monocentric Cohort 13
Association between Albumin Alterations and Renal Function in Patients with Type 2 Diabetes Mellitus 13
Zebra bodies recognition by artificial intelligence (ZEBRA): a computational tool for Fabry nephropathy 12
Correlation Between Renal Cortical Stiffness and Histological Determinants by Point Shear-Wave Elastography in Patients With Kidney Transplantation 12
Calcifying circulating cells: an uncharted area in the setting of vascular calcification in CKD patients 11
Kidney transplant in fabry disease: A revision of the literature 11
Atrial changes after kidney transplant: what diagnostic and therapeutic perspectives? 11
A Case Report of Tolvaptan Therapy for ADPKD Patients with COVID-19. The Need for Appropriate Counselling for Temporary Drug Discontinuation 11
Klotho-FGF23, cardiovascular disease, and vascular calcification: black or white? 10
Crystal nephropathy and amoxicillin: insights from international spontaneous reporting systems 10
Pediatric Urology: Contemporary Strategies from Fetal Life to Adolescence 10
Biomarkers of Kidney Injury in Very-low-birth-weight Preterm Infants: Influence of Maternal and Neonatal Factors 10
The need for clinical, genetic and radiological characterization of atypical polycystic kidney disease 9
The key role of phosphate on vascular calcification 9
Modifiers of Autosomal Dominant Polycystic Kidney Disease Severity: The Role of PKD1 Hypomorphic Alleles 9
Gene Panel Analysis in a Large Cohort of Patients With Autosomal Dominant Polycystic Kidney Disease Allows the Identification of 80 Potentially Causative Novel Variants and the Characterization of a Complex Genetic Architecture in a Subset of Families 9
Circulating miR-184 is a potential predictive biomarker of cardiac damage in Anderson–Fabry disease 9
Fifteen-year analysis of deceased kidney donation: A single transplant center experience in a region of northern Italy 9
Mineral and Electrolyte Disorders With SGLT2i Therapy 9
Is chronic kidney disease-mineral and bone disorder associated with the presence of endothelial progenitor cells with a calcifying phenotype? 9
Medullary sponge kidney: unusual finding in kidney transplant recipient 9
Impact of nephrotoxic drugs on urinary biomarkers of renal function in very preterm infants 9
An international cohort study of autosomal dominant tubulointerstitial kidney disease due to REN mutations identifies distinct clinical subtypes 9
New mineralocorticoid receptor antagonists: update on their use in chronic kidney disease and heart failure 9
Fabry Disease Nephropathy: Histological Changes With Nonclassical Mutations and Genetic Variants of Unknown Significance 9
Primary hyperoxaluria type 1 diagnosis in adult dialysis patients: prediction model assessment in a group of Italian patients 9
Diet and Physical Activity in Adult Dominant Polycystic Kidney Disease: A Review of the Literature 9
Urinary neutrophil gelatinase-associated lipocalin is a biomarker of delayed graft function after kidney transplantation 8
Impact of Baseline Clinical Variables on SGLT2i’s Antiproteinuric Effect in Diabetic Kidney Disease 8
Electrocardiogram evolution in Anderson-Fabry disease patients during follow-up in relation to specific treatment and cardiac disease progression 8
COVID-19 pandemic era: is it time to promote home dialysis and peritoneal dialysis? 8
Serum and Urinary Neutrophil Gelatinase-associated Lipocalin Monitoring in Normal Pregnancy Versus Pregnancies Complicated by Pre-eclampsia 8
Increase in Serum Amylase and Resistive Index After Kidney Transplant Are Biomarkers of Delayed Graft Function 8
Fibroblast Growth Factor 23: Mineral Metabolism and beyond 8
Intravenous Iron Replacement Therapy Improves Cardiovascular Outcomes in Hemodialysis Patients 8
Integrated use of Autosomal Dominant Polycystic Kidney Disease Prediction Tools and Risk Prognostication 8
Donor/recipient delta age: A possible risk for arterial stenosis in renal transplantation 8
Coupled Plasma Filtration Adsorption Application for Liver and Thyroid Toxins 8
Urinary neutrophil gelatinase-associated lipocalin at birth predicts early renal function in very low birth weight infants 8
Extreme placement of a tunneled cuffed catheter for hemodialysis 8
Hypoacusia and chronic renal dysfunction: new etiopathogenetic prospective 8
SGLT2 inhibitors, sodium and off-target effects: an overview 7
The link between homocysteine, folic acid and vitamin B12 in chronic kidney disease 7
Functional Abnormalities and Thyroid Nodules in Patients with End-stage Renal Disease 7
Correlations Between Cardiac Magnetic Resonance and Myocardial Histologic Findings in Fabry Disease 7
The importance of a multidisciplinary approach in two tricky cases: the perfect match for Fabry disease 7
Low protein diet with personalized support in advanced chronic kidney disease: association with disease progression, dialysis delay and mortality 7
Optimizing urine albumin-to-creatinine ratio testing and referral pathways for chronic kidney disease: a nominal group technique consensus study among Italian experts 7
Neutrophil Gelatinase-Associated Lipocalin Increases HLA-G(+)/FoxP3(+) T-Regulatory Cell Population in an In Vitro Model of PBMC 7
Tubular dysfunction after peritonectomy and chemohyperthermic treatment with cisplatin 7
Functional and histopathologic correlation in the fabry nephropathy with N215S genotype 7
The Kidney Donor Profile Index (KDPI) of Marginal Donors Allocated by Standardized Pretransplant Donor Biopsy Assessment: Distribution and Association With Graft Outcomes 7
The Role of Kidney Biopsy in Fabry Disease 7
Clinical Relevance of IFT140 Loss-of-Function Variants in Development of Renal Cysts 7
Comparison of Two Parathyroid Hormone Assays in Hemodialysis Patients 7
Vitamin B supplementation and nutritional intake of methyl donors in patients with chronic kidney disease: A critical review of the impact on epigenetic machinery 7
Effect of Vitamin D Receptor Activator Therapy on Vitamin D Receptor and Osteocalcin Expression in Circulating Endothelial Progenitor Cells of Hemodialysis Patients 7
Predictive model for delayed graft function based on easily available pre-renal transplant variables 7
Removal of free light chains in hemodialysis patients without multiple myeloma: A crossover comparison of three different dialyzers 7
Impact of 3 Major Maintenance Immunosuppressive Protocols on Long-term Clinical Outcomes: Result of a Large Multicenter Italian Cohort Study Including 5635 Renal Transplant Recipients 7
Deciphering the pathogenesis of the COL4-related hematuric nephritis: A genotype/phenotype study 7
Low-Level Mosaicism in Tuberous Sclerosis Complex (TSC): Diagnostic and Clinical Implications From Two Novel Cases and Literature Review 7
Mortality from cancer is not increased in elderly kidney transplant recipients compared to the general population: a competing risk analysis 7
Trapianto renale nelle malattie da errori congeniti del metabolismo = Kidney Transplantation and inborn errors of metabolism 7
Coexistence of Alport Syndrome and Fabry Disease in a Female with R112H Variant: Early Progression of Fabry Nephropathy 7
The impact of apoptosis and inflammation gene polymorphisms on transplanted kidney function 6
Combined plasmatic and tissue approach to membranous nephropathy - Proposal of a diagnostic algorithm including immunogold labelling: Changing the paradigm of a serum-based approach 6
Pulmonary Embolism in a Patient With ADPKD Treated With Tolvaptan: From the Clinical Experience to the Analysis of the Food and Drug Administration Adverse Event Reporting System Registry 6
Electrocardiogram analysis in Anderson-Fabry disease: a valuable tool for progressive phenotypic expression tracking 6
Alpine skiing and anaerobic performance in solid organ transplant recipients 6
Hepatorenal syndrome: Update on diagnosis and treatment 6
Hematopoietic Cell and Renal Transplantation in Plasma Cell Dyscrasia Patients 6
The Relationship between Timing of Pretransplant Kidney Biopsy, Graft Loss, and Survival in Kidney Transplantation: An Italian Cohort Study 6
Vitamin D effects on bone homeostasis and cardiovascular system in patients with chronic kidney disease and renal transplant recipients 6
Seroprevalence of a “new” bacterium, Simkania negevensis, in renal transplant recipients and in hemodialysis patients 6
Potential advantages of acute kidney injury management by mesenchymal stem cells 6
Hypothermic Oxygenated Perfusion in Extended Criteria Donor Kidney Transplantation-A Randomized Clinical Trial 6
Folic Acid and Vitamin B12 Administration in CKD, Why Not? 6
MR Brain Screening in ADPKD Patients 6
Vitamin D in Kidney Transplant Recipients: Mechanisms and Therapy 6
Native kidney function after renal transplantation combined with other solid organs in preemptive patients 6
Uremic Serum Impairs Osteogenic Differentiation of Human Bone Marrow Mesenchymal Stromal Cells 6
Identification of expanded T-cell clones by spectratyping in nonfunctioning kidney transplants 6
The Fabry Nephropathy in Patients with N215S Variant 6
Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial 6
Relationship between coronary artery disease and C-reactive protein levels in NSTEMI patients with renal dysfunction: A retrospective study 6
Preliminary experience of sequential use of normothermic and hypothermic oxygenated perfusion for donation after circulatory death kidney with warm ischemia time over the conventional criteria - a retrospective and observational study 6
Iloprost in Acute Post-kidney Transplant Atheroembolism: A Case Report of Two Successful Treatments 6
Importance of vascular calcification in kidney transplant recipients 6
Individualized Diets in Patients with Kidney Disease and Kidney Transplants: A Narrative Review 6
When native arteriovenous fistula is not possible: the permanent catheter is better 6
Incidence and Predictors of Postoperative Atrial Fibrillation in Kidney Transplant Recipients 5
Genetics and Autosomal Dominant Polycystic Kidney Disease Progression 5
The Off-Target Effects, Electrolyte and Mineral Disorders of SGLT2i 5
Totale 939
Categoria #
all - tutte 4.368
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.368


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20228 0 2 0 0 1 0 1 0 0 0 1 3
2022/20236 2 0 0 0 0 0 0 0 0 0 2 2
2023/202411 2 0 2 1 0 0 0 1 0 2 1 2
2024/202532 0 0 3 1 4 4 1 2 9 4 2 2
2025/2026936 8 0 5 17 14 9 4 8 3 49 742 77
Totale 998